Aurora kinase inhibitors as anti-cancer therapy - PubMed (original) (raw)
Review
Aurora kinase inhibitors as anti-cancer therapy
Warren Lok et al. Anticancer Drugs. 2010 Apr.
Abstract
Aurora kinases are serine and threonine kinases that function as key regulators of the mitosis process. There are three distinct human aurora kinases known as Aurora A, Aurora B, and Aurora C. Aurora A and Aurora B are overexpressed in a number of human cancers including non-small cell lung cancer, glioblastomas, and upper gastrointestinal adenocarcinomas. Given their association with tumorigenesis, both Aurora A and Aurora B have been targeted for cancer therapy. Currently, a number of selective and nonselective aurora kinase inhibitors are being tested in preclinical and clinical settings as anti-tumor agents. We review the biology of human aurora kinases, followed by an overview of inhibitors undergoing current clinical investigations.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous